FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004920565> ?p ?o ?g. }

• W3004920565 endingPage "607" @default.
• W3004920565 startingPage "598" @default.
• W3004920565 abstract "This retrospective study aims at investigating the effects of moderately hypofractionated radiation therapy (HRT) on acute and late toxicities as well as on early biochemical control and therapeutic efficiency compared to conventional radiation therapy (CRT) in prostate cancer.We analyzed 55 HRT patients irradiated with the total dose of 60 Gy in 20 fractions delivered over 4 weeks. These patients were compared to a control group of 55 patients who received CRT with a total of <78 Gy in 37-39 fractions delivered over circa 8 weeks. External beam radiation therapy (EBRT) was conducted using daily image-guided (cone beam CT) volumetric modulated arc therapy (VMAT) and a simultaneously integrated boost (SIB) for both groups to protect the rectum. Acute toxicities were evaluated according to Common Terminology Criteria for Adverse Events (CTCAE) v5, whereas chronic toxicities were assessed in accordance with LENT-SOMA. Patient traits were compared by implementing t‑tests and Wilcoxon-Whitney tests for continuous variables, whereas discrete characteristics were evaluated by applying two-tailed Fisher's exact tests. In addition, we calculated average treatment effects (ATE). Thereby, propensity score matching (PSM) based on nearest-neighbor matching considering age, comorbidities, and risk stratification as covariates was applied. The statistical analysis was conducted using Stata 14.2 (StataCorp LLC, TX, USA).As confirmed by the descriptive tests, the ATE revealed that the intensity and occurrence of urinary frequency (p = 0.034) and proctitis (p = 0.027) significantly decreased for the HRT group, whereas all other acute toxicities did not differ significantly between the HRT and CRT groups. For late toxicities, neither statistical tests nor ATE estimation showed significant differences. Also, no significant difference was found regarding the decrease in prostate specific antigen (PSA) after a median follow-up of 13 months (range 2-28 months), which indicates biochemical freedom from progression.HRT offers several medical and economic advantages and should therefore be considered as a useful alternative to CRT." @default.
• W3004920565 created "2020-02-14" @default.
• W3004920565 creator A5006783014 @default.
• W3004920565 creator A5010436347 @default.
• W3004920565 creator A5037080576 @default.
• W3004920565 creator A5046683204 @default.
• W3004920565 creator A5074701624 @default.
• W3004920565 date "2020-02-10" @default.
• W3004920565 modified "2023-09-27" @default.
• W3004920565 title "Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities" @default.
• W3004920565 cites W1486355582 @default.
• W3004920565 cites W1983186731 @default.
• W3004920565 cites W1993681878 @default.
• W3004920565 cites W2000445173 @default.
• W3004920565 cites W2015981950 @default.
• W3004920565 cites W2033942571 @default.
• W3004920565 cites W2093867637 @default.
• W3004920565 cites W2099051717 @default.
• W3004920565 cites W2111180711 @default.
• W3004920565 cites W2130514725 @default.
• W3004920565 cites W2159805452 @default.
• W3004920565 cites W2165244734 @default.
• W3004920565 cites W2172038823 @default.
• W3004920565 cites W2290283472 @default.
• W3004920565 cites W2337386322 @default.
• W3004920565 cites W2465092116 @default.
• W3004920565 cites W2469323349 @default.
• W3004920565 cites W2526461845 @default.
• W3004920565 cites W2585266360 @default.
• W3004920565 cites W2599505697 @default.
• W3004920565 cites W2601353955 @default.
• W3004920565 cites W2603384438 @default.
• W3004920565 cites W2603624851 @default.
• W3004920565 cites W2736966846 @default.
• W3004920565 cites W2772705486 @default.
• W3004920565 cites W2794287294 @default.
• W3004920565 cites W2885658755 @default.
• W3004920565 cites W2896703180 @default.
• W3004920565 cites W2897935268 @default.
• W3004920565 cites W2900728509 @default.
• W3004920565 cites W2946929414 @default.
• W3004920565 cites W2952903287 @default.
• W3004920565 cites W4248518863 @default.
• W3004920565 cites W4253473049 @default.
• W3004920565 doi "https://doi.org/10.1007/s00066-020-01589-w" @default.
• W3004920565 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7305256" @default.
• W3004920565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32040691" @default.
• W3004920565 hasPublicationYear "2020" @default.
• W3004920565 type Work @default.
• W3004920565 sameAs 3004920565 @default.
• W3004920565 citedByCount "7" @default.
• W3004920565 countsByYear W30049205652021 @default.
• W3004920565 countsByYear W30049205652022 @default.
• W3004920565 countsByYear W30049205652023 @default.
• W3004920565 crossrefType "journal-article" @default.
• W3004920565 hasAuthorship W3004920565A5006783014 @default.
• W3004920565 hasAuthorship W3004920565A5010436347 @default.
• W3004920565 hasAuthorship W3004920565A5037080576 @default.
• W3004920565 hasAuthorship W3004920565A5046683204 @default.
• W3004920565 hasAuthorship W3004920565A5074701624 @default.
• W3004920565 hasBestOaLocation W30049205651 @default.
• W3004920565 hasConcept C121608353 @default.
• W3004920565 hasConcept C126322002 @default.
• W3004920565 hasConcept C126894567 @default.
• W3004920565 hasConcept C141071460 @default.
• W3004920565 hasConcept C167135981 @default.
• W3004920565 hasConcept C17923572 @default.
• W3004920565 hasConcept C2777793932 @default.
• W3004920565 hasConcept C2779134260 @default.
• W3004920565 hasConcept C2779810446 @default.
• W3004920565 hasConcept C2780192828 @default.
• W3004920565 hasConcept C2780479503 @default.
• W3004920565 hasConcept C2989005 @default.
• W3004920565 hasConcept C509974204 @default.
• W3004920565 hasConcept C71924100 @default.
• W3004920565 hasConceptScore W3004920565C121608353 @default.
• W3004920565 hasConceptScore W3004920565C126322002 @default.
• W3004920565 hasConceptScore W3004920565C126894567 @default.
• W3004920565 hasConceptScore W3004920565C141071460 @default.
• W3004920565 hasConceptScore W3004920565C167135981 @default.
• W3004920565 hasConceptScore W3004920565C17923572 @default.
• W3004920565 hasConceptScore W3004920565C2777793932 @default.
• W3004920565 hasConceptScore W3004920565C2779134260 @default.
• W3004920565 hasConceptScore W3004920565C2779810446 @default.
• W3004920565 hasConceptScore W3004920565C2780192828 @default.
• W3004920565 hasConceptScore W3004920565C2780479503 @default.
• W3004920565 hasConceptScore W3004920565C2989005 @default.
• W3004920565 hasConceptScore W3004920565C509974204 @default.
• W3004920565 hasConceptScore W3004920565C71924100 @default.
• W3004920565 hasIssue "7" @default.
• W3004920565 hasLocation W30049205651 @default.
• W3004920565 hasLocation W30049205652 @default.
• W3004920565 hasLocation W30049205653 @default.
• W3004920565 hasLocation W30049205654 @default.
• W3004920565 hasOpenAccess W3004920565 @default.
• W3004920565 hasPrimaryLocation W30049205651 @default.
• W3004920565 hasRelatedWork W1586374228 @default.
• W3004920565 hasRelatedWork W2002120878 @default.

• next